Reduced survival in patients with "coronary microvascular disease"

Terence Lin1, Stephen Rechenmacher, Shuja Rasool

  • 1Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California.

Insights

Coronary microvascular disease (µVD) is a common cause of chest pain with abnormal stress tests. Patients with µVD have worse survival than the general population but better survival than those with significant epicardial coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Testing

Background:

  • Coronary microvascular disease (µVD) is frequently implicated in patients presenting with chest pain, abnormal stress tests, and non-obstructive coronary artery disease (CAD).
  • This condition leads to significant healthcare utilization and costs, yet its long-term prognostic implications remain unclear.
  • Understanding the survival impact of µVD is crucial for patient management and risk stratification.

Purpose of the Study:

  • To investigate the long-term survival outcomes of patients diagnosed with coronary microvascular disease (µVD) presenting with chest pain and abnormal stress tests.
  • To compare the mortality rates of patients with µVD against those with significant epicardial coronary artery disease (CAD) and age- and gender-matched controls.

Main Methods:

  • A cohort of 9941 patients undergoing exercise stress tests for chest pain evaluation was retrospectively analyzed.
  • 935 patients with positive stress tests and coronary angiograms within one year were included.
  • Patients were categorized into significant epicardial CAD (≥70% stenosis) or coronary µVD (no significant stenosis).

Main Results:

  • Patients with coronary µVD (n=611) were younger and exhibited distinct demographic and physiological characteristics compared to those with significant epicardial CAD (n=324).
  • All-cause mortality was significantly higher in the coronary µVD group compared to age- and gender-matched population controls (p < 0.0001).
  • However, patients with coronary µVD demonstrated better survival rates than those with significant epicardial CAD.

Conclusions:

  • Coronary microvascular disease (µVD) is a prevalent diagnosis in patients with chest pain and positive stress tests, often without significant epicardial coronary artery disease.
  • While associated with increased mortality compared to the general population, µVD carries a more favorable long-term survival prognosis than significant obstructive coronary artery disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...